Blood transfusion

FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease

Retrieved on: 
Friday, February 4, 2022

Enjaymo is the only approved treatment to inhibit red blood cell destruction in CAD and help stop the chain reaction from the start.

Key Points: 
  • Enjaymo is the only approved treatment to inhibit red blood cell destruction in CAD and help stop the chain reaction from the start.
  • For the first time, we have a treatment that targets complement-mediated hemolysis, which is the underlying cause of the red blood cell destruction in many CAD patients.
  • Dosage interruptions due to an adverse reaction occurred in 17 percent (4/24) of patients who received Enjaymo.
  • Following the completion of the 26-week treatment period of CARDINAL (Part A), eligible patients continued to receive Enjaymo in an extension study.

Reevaluating Blood Transfusions in the $2.5 Billion Blood Screening Market

Retrieved on: 
Tuesday, February 1, 2022

This is according to data published in World Market for Blood Screening , the latest report by medical market research firm Kalorama Information.

Key Points: 
  • This is according to data published in World Market for Blood Screening , the latest report by medical market research firm Kalorama Information.
  • Blood screening is a medical process that scans the blood for infectious diseases or conditions.
  • Blood transfusions, important components of the blood screening market, have become so commonplace that it is easy to forget that blood is an organ, and the transfusion is akin to an organ transplant and should be performed only when absolutely necessary.
  • For more information on blood screening, blood transfusions, and related topics purchase Kalorama Information's World Market for Blood Screening (published January 2022) at: https://kaloramainformation.com/product/world-market-for-blood-screening/ .

$2.1 Billion Immunohematology Markets - Global Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 & 2021-2026 - ResearchAndMarkets.com

Retrieved on: 
Friday, January 21, 2022

The "Immunohematology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Immunohematology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • The global immunohematology market reached a value of US$ 2.1 Billion in 2020.
  • Immunohematology refers to a branch of medical sciences that studies blood and blood-forming tissues in relation to the immune system.
  • What is the structure of the global immunohematology market and who are the key players?

Insights on the Blood Transfusion Diagnostics Global Market to 2027 - Rising Demand for Donor Screening is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, January 17, 2022

The global blood transfusion diagnostics market size is expected to reach USD 5.8 billion by 2027.

Key Points: 
  • The global blood transfusion diagnostics market size is expected to reach USD 5.8 billion by 2027.
  • The growing prevalence of chronic diseases coupled with increasing demand for disease screening is significantly driving the market growth.
  • Some of the chronic infectious diseases such as hepatitis B, hepatitis C, HIV, and syphilis create the need for accurate donor screening, further driving the market growth.
  • There is an increasing risk of Transfusion-transmitted Infections (TTIs) that has led to high demand for donor screening.

Air Methods Thanks Governor Hochul for signing lifesaving blood transfusion bill

Retrieved on: 
Thursday, December 23, 2021

Air medical crews in New York have historically been prohibited from initiating a blood transfusion from blood stores at their base, because outdated state regulations required these services to operate as blood bank distribution centers.

Key Points: 
  • Air medical crews in New York have historically been prohibited from initiating a blood transfusion from blood stores at their base, because outdated state regulations required these services to operate as blood bank distribution centers.
  • Air Methods ( www.airmethods.com ) is the leading air medical service, delivering lifesaving care to more than 70,000 people every year.
  • With nearly 40 years of air medical experience, Air Methods is the preferred partner for hospitals and one of the largest community-based providers of air medical services.
  • Air Methods fleet of owned, leased or maintained aircraft features more than 450 helicopters and fixed wing aircraft.

Hepatitis Testing/Diagnosis Market Global Forecast to 2026: Growth Opportunities Due to Rising Technological Advancements in Molecular Diagnostics - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 15, 2021

The growth of the global hepatitis testing market is being driven by factors such as the high burden of hepatitis, increasing blood transfusion and donations, benefits of POC instruments and kits, and awareness initiatives on hepatitis.

Key Points: 
  • The growth of the global hepatitis testing market is being driven by factors such as the high burden of hepatitis, increasing blood transfusion and donations, benefits of POC instruments and kits, and awareness initiatives on hepatitis.
  • High cost of nucleic acid tests, lack of mandates for nucleic acid tests in developing countries and unfavorable reimbursement scenarios are expected to restrain hepatitis market growth.
  • Emerging markets, rising technological advancements in molecular diagnostics, and growth in the biotechnology and biopharmaceutical industries are expected to offer strong growth opportunities for players in the market.
  • Based on disease type, the hepatitis testing market is segmented into hepatitis B, hepatitis C, and other hepatitis diseases (hepatitis A, D, and E).

Blood and Blood Components Global Market Report 2021 Featuring American Red Cross, Australian Red Cross Blood Service, Abbott Laboratories, Blood Centers of America, and Becton, Dickinson & Co - ResearchAndMarkets.com

Retrieved on: 
Monday, December 13, 2021

Major players in the blood and blood components market are American Red Cross, Australian Red Cross Blood Service, Abbott Laboratories, Blood Centers of America, and Becton, Dickinson & Co.

Key Points: 
  • Major players in the blood and blood components market are American Red Cross, Australian Red Cross Blood Service, Abbott Laboratories, Blood Centers of America, and Becton, Dickinson & Co.
  • The blood and blood components market consist of sales of blood and blood component.
  • The blood and blood components market covered in this report is segmented by product into whole blood, blood components.
  • Global Blood and Blood Components Market, Segmentation by Blood Components, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

Global $8.4 Bn Intravenous Infusion Pumps (Volumetric, Insulin, Syringe, Enteral, Ambulatory, Implantable Pumps) Markets Analysis & Forecasts, 2016-2020 & 2021-2028 - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 25, 2021

The "Global Intravenous Infusion Pumps Market Report 2021-2028" has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Intravenous Infusion Pumps Market Report 2021-2028" has been added to ResearchAndMarkets.com's offering.
  • According to a study conducted by Mindray Medical Company in 2018, medical pumps are the most conventional hospital rentals equipment.
  • FDA also launched a website that gives peculiar information about medical pumps to the patients, users, and other stakeholders.
  • Chapter 3 Intravenous Infusion Pump Market: Variables, Trends, & Scope
    Chapter 4 Intravenous Infusion Pumps Market: Product Segment Analysis
    4.1.1.1 Volumetric Infusion Pumps market, 2016 - 2028 (USD Million)

Terumo Corporation and Diabeloop SA Enter Into Comprehensive Strategic Partnership Agreement to Expand Their Diabetes Care Offerings

Retrieved on: 
Thursday, November 18, 2021

It analyzes the data in real time, and decides whether to maintain current insulin settings or adjust insulin delivery.

Key Points: 
  • It analyzes the data in real time, and decides whether to maintain current insulin settings or adjust insulin delivery.
  • Based on this strategic partnership agreement, the two companies will accelerate and strengthen collaboration for AID systems.
  • "It is our great pleasure to enter into this comprehensive strategic partnership agreement.
  • "We are thrilled to reinforce our partnership with global leader Terumo with this new agreement and expand our contribution to personalized diabetes management via Diabeloop's interoperable solution.

Research Publication Demonstrates Utility of Applied DNA’s LinearDNA™ in Non-Viral CAR T Manufacturing Systems

Retrieved on: 
Tuesday, November 9, 2021

The study , titled Enzymatically produced piggyBac transposon vectors for efficient non-viral manufacturing of CD19-specific CAR T cells, details the utility of LinearDNA in the cost-effective production of preclinical CAR T cells.

Key Points: 
  • The study , titled Enzymatically produced piggyBac transposon vectors for efficient non-viral manufacturing of CD19-specific CAR T cells, details the utility of LinearDNA in the cost-effective production of preclinical CAR T cells.
  • We found CAR T efficacy of the LinearDNA system versus the plasmid system to be identical.
  • Applied DNA is commercializing LinearDNA, its proprietary, large-scale polymerase chain reaction (PCR)-based manufacturing platform that allows for the large-scale production of specific DNA sequences.
  • The LinearDNA platform has utility in the nucleic acid-based in vitro diagnostics and preclinical nucleic acid-based drug development and manufacturing market.